HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q4 2023

SEC EDGAR SourceSEC Filings

Top Holdings49 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
PDDPDD
ADR

PDD HOLDINGS INC

10.1M$1.5B29.8%$93.89+55.83%
7 qtrssince 2022-Q2
Increased
82
ONCONC
ADR

BEIGENE LTD-ADR

5.2M$933.7M18.8%$134.02+34.57%
21 qtrssince 2018-Q4
Unchanged
0
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

29.2M$473.7M9.5%$21.97-29.50%
14 qtrssince 2020-Q3
Decreased
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

6M$360.1M7.3%$50.98+18.02%
15 qtrssince 2020-Q2
Decreased
0

MICROSOFT CORP

729,400$274.3M5.5%$302.56+22.46%
7 qtrssince 2022-Q2
Decreased
0

SALESFORCE.COM INC

747,537$196.7M4.0%$206.97+25.61%
16 qtrssince 2020-Q1
Decreased
0

TAKE-TWO INTERACTIVE SOFTWRE

783,000$126M2.5%$145.47+10.64%
3 qtrssince 2023-Q2
Unchanged
0

AMAZON.COM INC

811,900$123.4M2.5%$126.83+19.80%
7 qtrssince 2022-Q2
Increased
53

DANAHER CORP

471,100$109M2.2%$225.13+1.68%
3 qtrssince 2023-Q2
Increased
84

DOORDASH INC - A

1M$102.1M2.1%$116.24-14.93%
13 qtrssince 2020-Q4
Decreased
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

1.2M$94.6M1.9%$96.55-23.44%
7 qtrssince 2022-Q2
Decreased
0
RYZBRYZBDelisted

RAYZEBIO INC

1.1M$66M1.3%
2 qtrssince 2023-Q3
Decreased
0
BIDUBIDU
ADR

BAIDU INC - SPON ADR

535,400$63.8M1.3%$148.69-19.91%
4 qtrssince 2023-Q1
Unchanged
0

MOODY'S CORP

155,846$60.9M1.2%$381.990.00%
1 qtr
New
68

CYTEK BIOSCIENCES INC

6.7M$60.7M1.2%$20.96-56.49%
10 qtrssince 2021-Q3
Unchanged
0

BRIDGEBIO PHARMA INC

1.4M$56.2M1.1%$28.25+42.88%
19 qtrssince 2019-Q2
Decreased
0
ENFNENFNDelisted

ENFUSION INC

5M$48.3M1.0%
9 qtrssince 2021-Q4
Unchanged
0
JDJD
ADR

JD.COM INC-ADR

1.5M$41.9M0.8%$35.24-22.59%
21 qtrssince 2018-Q4
Increased
67

COUPANG INC

2.2M$35.9M0.7%$25.60-36.77%
10 qtrssince 2021-Q3
Decreased
0
HTHTHTHT
ADR

H WORLD GROUP LTD

935,920$31.3M0.6%$42.46-26.94%
15 qtrssince 2020-Q2
Decreased
0
$5B
AUM
49
Positions
Q4 2023
Filing
Rating · 2.0
Quarterly Portfolio Change
-18%Q3'22$3.8B+25%Q4'22$4.7B+19%Q1'23$5.6B-17%Q2'23$4.7B-5%Q3'23$4.5B+11%Q4'23$5B
Activity profile
$ moved · Q4'23
New4%Increased56%Decreased29%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.9 years
<1Q2%1-4Q14%1-2Y10%2Y+73%

HHLR ADVISORS, LTD. manages $5B across 49 positions as of Q4 2023. Top holdings: PDD (29.8%), ONC (18.8%), BEKE (9.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q4 2023 Summary

Active quarter - 1 new positions, 12 exits, 4 increased. Top move: DHR (INCREASED, conviction 84). Portfolio: $5.0B across 49 positions.

Top holdings by portfolio weight

Total AUM$5B
PDD29.81%
ONC18.82%
BEKE9.55%
LEGN7.26%
MSFT5.53%
CRM3.96%
TTWO2.54%
AMZN2.49%
DHR2.20%
DASH2.06%
Other1.91%

Portfolio allocation by GICS sector

Sectors9
Consumer Cyclical39.04%
Healthcare31.95%
Technology10.09%
Real Estate9.55%
Communication Services4.32%
Unknown2.33%
Financial Services1.31%
Consumer Defensive1.06%
Industrials0.35%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record35
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used